Grammy award-winning singer, Justin Timberlake, has revealed that he’s been dealing with health issues, including a Lyme disease diagnosis.“If you’ve experienced this disease or know someone who has — ...

The Scotsman Life Science Conference 2025 will bring together industry leaders, innovators and researchers to discuss the ...

AGC Biologics, your friendly CDMO expert, today announced a development and manufacturing services agreement with specialty vaccine company Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) to supply ...

The Centers for Disease Control and Prevention (CDC) is warning about the deadly mosquito-borne chikungunya virus, which is ...

Valneva (VALN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Chikungunya virus disease, a debilitating mosquito-borne (Aedes spp) illness caused by an alphavirus, chikungunya virus, is usually endemic in regions with tropical climates.1 Since the beginning of ...

Scotland’s life sciences sector is smashing the targets set for it by the Industry Leadership Group, surpassing an £8bn ...

Valneva SE (VALN) Overview. Read detailed company information including current share prices, financial summary, directors, announcements, dividends & news. Find out more at Intelligent Investor ...

Most of the locally-acquired cases of chikungunya appear to be clustered around two towns near Marseille, Toulon and ...

About Valneva SE We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.

Saint-Herblain, France, June 26, 2025 – Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s ...

Valneva is providing this information as of the date of this press release and disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a ...